SkinHealth Systems Inc. Cash Flow Statement
SKIN|5 years of annual SEC 10-K data (FY2021-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 5 fiscal years. All figures from audited SEC 10-K filings.
SkinHealth Systems Inc. generated $22M in operating cash flow and $18M in free cash flow in FY2025. Free cash flow margin was 4.5% of revenue.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.21 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Income | -$100.1M | $44.2M | -$378.8M | -$29.2M | -$1.6M |
| Depreciation & Amortization | $11.3M | $7.2M | $4.5M | $2.6M | $1.4M |
| Operating Cash Flow | $21.8M | -$106.6M | -$28.4M | -$12.4M | $1.7M |
| Capital Expenditures | $3.8M | $10.8M | $11.2M | $3.5M | $8.8M |
| Free Cash Flow | $17.9M | -$117.4M | -$39.6M | -$15.9M | -$7.0M |
| Share Buybacks | $30.2M | $160.0M | $0 | $154.0K | $0 |
| FCF Margin | 4.5% | -32.1% | -15.2% | -13.4% | -4.2% |